Homozygous mice with mutant protein FUS[1-359] overexpression: Innovative possibilities for ALS treatment
Introduction: This study investigates a mouse model with overexpression of the mutant FUS[1-359] protein, which can be used to evaluate the effectiveness of gene therapy and other pharmacological interventions for amyotrophic lateral sclerosis (ALS). The model enhances the deeper understanding of th...
Saved in:
| Main Author: | Nikita S. Zhunusov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Belgorod National Research University
2024-12-01
|
| Series: | Research Results in Pharmacology |
| Subjects: | |
| Online Access: | https://rrpharmacology.ru/index.php/journal/article/view/554 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ALS-linked mutant TDP-43 in oligodendrocytes induces oligodendrocyte damage and exacerbates motor dysfunction in mice
by: Mai Horiuchi, et al.
Published: (2024-11-01) -
Whole blood transcriptome profile identifies motor neurone disease RNA biomarker signatures
by: Sulev Kõks, et al.
Published: (2025-01-01) -
Optineurin overexpression ameliorates neurodegeneration through regulating neuroinflammation and mitochondrial quality in a murine model of amyotrophic lateral sclerosis
by: Shumin Zhao, et al.
Published: (2025-02-01) -
A bibliometric analysis of gene editing and amyotrophic lateral sclerosis (from 2004 to 2024)
by: Hejia Wan, et al.
Published: (2024-11-01) -
Pain in Amyotrophic Lateral Sclerosis Is Underrated
by: Soyoung Kwak, et al.
Published: (2024-12-01)